Survival benefit with adjuvant radiation therapy in surgically resected pancreatic cancer

被引:0
|
作者
Greco, J. A. [1 ]
Castaldo, E. T. [1 ]
Feurer, I. D. [1 ]
Pinson, C. W. [1 ]
Chakravarthy, A. B. [1 ]
Merchant, N. B. [1 ]
Parikh, A. A. [1 ]
机构
[1] Vanderbilt Univ, Nashville, TN USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:108 / 109
页数:2
相关论文
共 50 条
  • [41] Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy
    Snyder, R. A.
    Castaldo, E. T.
    Bailey, C. E.
    Phillips, S. E.
    Chakravarthy, A. B.
    Merchant, N. B.
    [J]. INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2012, 2012
  • [42] The role of sequential radiation following adjuvant chemotherapy in resected pancreatic cancer
    Shinde, Ashwin
    Verma, Vivek
    Li, Richard
    Glaser, Scott
    Raoof, Mustafa
    Warner, Susanne G.
    Chung, Vincent
    Singh, Gagandeep
    Chen, Yi-Jen
    Goodman, Karyn A.
    Amini, Arya
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (03) : 462 - 473
  • [43] The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis
    Lin, Zhuang-Bin
    Song, Jian-Yuan
    Li, An-Chuan
    Chen, Cheng
    Huang, Xiao-Xue
    Xu, Ben-Hua
    [J]. PLOS ONE, 2020, 15 (12):
  • [44] Adjuvant Chemo-Radiotherapy for Resectable Pancreatic Head Cancer: The Real Benefit of Radiation Therapy
    Masi, A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S153 - S153
  • [45] VEGF, angiogenesis and adjuvant therapy outcomes in resected pancreatic cancer.
    Khorana, AA
    Hu, YC
    Ryan, CK
    Komorowski, RA
    Hostetter, G
    Ahrendt, SA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 315S - 315S
  • [46] Association of diabetes with perineural invasion and overall survival in surgically resected patients with pancreatic cancer
    Shama, M. A.
    Tanaka, M.
    Curley, S. A.
    Abbruzzese, J. L.
    Li, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] Gemcitabine Adjuvant Therapy for Resected Pancreatic Cancer A Meta-analysis
    Yu, Zhong
    Zhong, Wa
    Tan, Zhi-Ming
    Wang, Ling-Yun
    Yuan, Yu-Hong
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (03): : 322 - 325
  • [48] Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancer
    Liu, Zuqiang
    Luo, Guopei
    Guo, Meng
    Jin, Kaizhou
    Xiao, Zhiwen
    Liu, Liang
    Liu, Chen
    Xu, Jin
    Ni, Quanxing
    Long, Jiang
    Yu, Xianjun
    [J]. PANCREATOLOGY, 2015, 15 (03) : 253 - 258
  • [49] Delta Radiomic Features Predict Failure and Survival Outcomes for Surgically Resected Pancreatic Cancer Patients Treated with Neoadjuvant Therapy
    Wang, K.
    Elamir, A.
    Karalis, J.
    Enrico, S.
    Polanco, P.
    Aguilera, T.
    Ligorio, M.
    Wang, J.
    [J]. MEDICAL PHYSICS, 2022, 49 (06) : E587 - E587
  • [50] Survival impact of neoadjuvant therapy in resected pancreatic cancer.
    Mirkin, Katelin Anne
    Hollenbeak, Christopher S.
    Wong, Joyce
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)